Location History:
- Rochester, MN (US) (2008)
- Austin, TX (US) (2017)
- Minneapolis, MN (US) (2016 - 2020)
Company Filing History:
7 out of 2,313 
1 out of 2 
1 out of 1,458 
Years Active: 2008-2025
Title: **Zigang Dong: Pioneering Innovations in Skin Cancer Treatment**
Introduction
Zigang Dong, an accomplished inventor based in Minneapolis, MN, is credited with seven patents focused on innovative solutions for skin cancer treatment and skincare formulations. His expertise and dedication to advancing medical science have made him a notable figure in the field of oncology.
Latest Patents
Dong’s recent patents showcase his commitment to addressing skin cancer challenges. One significant technique involves administering a therapeutically effective amount of a p53-related protein kinase (PRPK) inhibitor to treat skin cancer or reduce the risk of its development. This includes compositions featuring various anti-solar ultraviolet (anti-sUV) combinations such as avobenzone and octinoxate, aimed at preventing skin cancer.
Furthermore, Dong has developed methods employing herbacetin for cancer treatment. This includes specific applications of 3,5,7,8,4'-Pentahydroxyflavone, a compound effective in treating cancers by targeting ornithine decarboxylase (ODC). His contributions also extend to creating dermal products for treating sunburn and skin cancer, highlighting the versatile applications of his findings.
Career Highlights
Zigang Dong has worked with prestigious institutions such as the University of Minnesota and Wellgen, Inc. His tenure at these organizations has allowed him to collaborate with leading experts and foster innovations that can significantly impact public health.
Collaborations
Throughout his career, Dong has collaborated with prominent figures in the field, including Ann M. Bode and Kanamata Reddy. These partnerships have enriched his research and paved the way for impactful advancements in cancer treatment.
Conclusion
Zigang Dong's contributions to skin cancer treatment illustrate his profound commitment to innovation and medical advancement. With a portfolio of seven patents and significant collaborations, he continues to be an influential inventor in the realm of cancer therapies, bringing hope and effective solutions to patients worldwide.